Remus Pharmaceuticals Limited (NSE:REMUS)

Remus Pharmaceuticals Revenue

Remus Pharmaceuticals had revenue of 4.00B INR in the half year ending September 30, 2025, with 1,278.06% growth. This brings the company's revenue in the last twelve months to 7.48B, up 63.84% year-over-year. In the fiscal year ending March 31, 2025, Remus Pharmaceuticals had annual revenue of 6.20B with 191.33% growth.

• Revenue (ttm): 7.48B
• Revenue Growth: +63.84%
• P/S Ratio: 1.16
• Revenue / Employee: 109.99M
• Employees: 68
• Market Cap: 8.64B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	6.20B	4.07B	191.33%
Mar 31, 2024	2.13B	1.68B	371.81%
Mar 31, 2023	451.32M	204.15M	82.59%
Mar 31, 2022	247.17M	59.09M	31.42%
Mar 31, 2021	188.08M	63.89M	51.44%